Skip to main content
. 2024 May 15;110(9):5545–5562. doi: 10.1097/JS9.0000000000001650

Figure 8.

Figure 8

The decision curve analysis based on the coagulopathy and coagulopathy-hematoma thickness (X1) models were compared in the training and validation groups. (A) Calibration curve analysis of the coagulopathy model in the training group. (B) Calibration curve analysis of the X1 model in the training group. (C) Calibration curve analysis of the coagulopathy model in the validation group. (D) Calibration curve analysis of the X1 model in the validation group.